Huseyin Mertsoylu Selected Research

Radiotherapy

4/2024	Letter to Editor: "The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors".
1/2020	Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
1/2020	Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.
1/2020	Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
1/2020	Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study.
10/2019	Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
9/2018	Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
11/2017	A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; a hospital-based retrospective case series study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huseyin Mertsoylu Research Topics

Disease

11	Inflammation (Inflammations) 01/2024 - 06/2015
9	Neoplasms (Cancer) 10/2023 - 04/2009
7	Nasopharyngeal Carcinoma 03/2024 - 01/2020
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2018
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2021 - 08/2012
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
2	Osteoradionecrosis 03/2024 - 01/2024
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2024 - 10/2023
2	Trismus (Lockjaw) 01/2024 - 01/2024
2	Adenocarcinoma 01/2022 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 05/2019
2	Infections 05/2016 - 06/2015
1	Stomatitis 04/2024
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024
1	Cachexia 10/2023
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Pulmonary Embolism 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Osteonecrosis (Kienbock's Disease) 07/2020
1	Ovarian Neoplasms (Ovarian Cancer) 07/2020
1	Hypertension (High Blood Pressure) 07/2020
1	Pulmonary Hypertension 07/2020
1	Ischemia 07/2020
1	Embolism (Embolus) 07/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Lymphopenia (Lymphocytopenia) 10/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2018
1	Hemorrhage 01/2018
1	Anemia 01/2018
1	Thrombocytosis (Thrombocythemia) 06/2015
1	Leukocytosis (Pleocytosis) 06/2015
1	Astrocytoma (Pilocytic Astrocytoma) 10/2012
1	Cholangiocarcinoma 08/2012
1	Synovial Sarcoma (Synovioma) 01/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2009
1	Lymphoma (Lymphomas) 04/2009

Drug/Important Bio-Agent (IBA)

5	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2015
3	AlbuminsIBA 01/2022 - 09/2018
3	C-Reactive ProteinIBA 01/2020 - 06/2015
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2018
2	abirateroneIBA 10/2019 - 05/2019
2	Abiraterone AcetateIBA 10/2019 - 05/2019
2	ProcalcitoninIBA 05/2016 - 06/2015
1	Indicators and Reagents (Reagents)IBA 10/2023
1	human ERBB2 proteinIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Bevacizumab (Avastin)FDA Link 07/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 05/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2015
1	MetalsIBA 08/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Ifosfamide FDA LinkGeneric 01/2011

Therapy/Procedure

21	Chemoradiotherapy 03/2024 - 01/2018
8	Radiotherapy 04/2024 - 11/2017
3	Drug Therapy (Chemotherapy) 09/2023 - 11/2017
2	Therapeutics 01/2021 - 10/2012
2	Castration 10/2019 - 05/2019
1	Gastrectomy 01/2021
1	Retreatment 10/2018
1	Stents 08/2012
1	Nephrectomy 04/2009